Efficacy and safety of surufatinib plus PD-1/PD-L1 inhibitors as first-line maintenance therapy in extensive-stage small cell lung cancer.

Detalles Bibliográficos
Publicado en:	Holistic Integrative Oncology Vol. 5; no. 1; pp. 1 - 11
Autores principales:	Tao, Haitao, Chen, Jianhua, Lv, Dongqing, Wang, Jinliang, Ma, Junxun, Yi, Tienan, Wu, Shikai, Zhou, Xiangdong, Zhang, Xingxing, Chen, Dongmei, Fan, Songhua, Zhong, Chen, Guan, Chunyu, Shi, Michael, Su, Weiguo, Hu, Yi
Formato:	research tables/charts Journal Article
Publicado:	Springer Nature 7/28/2026
Acceso en línea:	Ver este registro en EBSCOhost